Skip to main content
Age logoLink to Age
. 2006 May 20;28(1):77–84. doi: 10.1007/s11357-006-9000-1

Design for a study to determine optimal dosage of ascorbic acid and alpha-tocopherol in humans

Leta R Moser 1,2, Alfred B Ordman 1,3,
PMCID: PMC2464720  PMID: 23598680

Abstract

Some clinical trials of vitamins C and E have neglected important design features. Our objective was to demonstrate a detailed design that includes essential elements for an effective study of these vitamins in vivo. While taking 400 IU (international units) of vitamin E, subjects took different dosages of vitamin C during three distinct periods. Dosages were 200 mg in food, 500 mg as supplements twice a day (500 × 2), and 1,000 mg as supplements twice a day (1000 × 2). Ten participants spent 3 weeks at each dosage before plasma was drawn on two consecutive days. Final samples were taken after a week with no supplementation. Selected by investigators at four institutions, endpoints were protein carbonyls, TBARs (thiobarbituric reactive substances), and Heinz body formation in RBCs (red blood cells). TBARs and protein carbonyls did not change significantly with dosage. However, Heinz body formation increased at either higher or lower intakes of vitamin C. Even with daily vitamin E, Heinz bodies were significantly fewer at 500 × 2. Results indicate that even with 400 IU vitamin E daily, it is possible to distinguish the effect of different levels of vitamin C with Heinz bodies. This effect may be due to pro-oxidant action of vitamin C or to prolonged survival of RBCs.

Key words: antioxidants, ascorbic acid, free radicals, Heinz bodies, protein carbonyls, TBARs, tocopherol, vitamin C, vitamin E

Full Text

The Full Text of this article is available as a PDF (269.2 KB).

Abbreviations

AA

ascorbic acid/vitamin C

AGE

American Aging Association

ANOVA

Analysis of variance

AT

dl-alpha-tocopheryl-acetate/vitamin E

DCIP

dichlorophenol-indophenol

DNP

dinitrophenol

ELISA

enzyme-linked immunosorbent assay

IU

international units

NIH

National Institutes of Health

RBC

red blood cells

SUP

supplement

TBARS

thiobarbituric acid reactive substances

UL

Upper limit

500 × 2

500 mg AA twice a day

1000 × 2

1000 mg AA twice a day

References

  1. American Aging Assocation (AGE) Conference (2003, June 6-9) Nutritional Modulation of Aging and Age-Related Diseases
  2. Annual Meeting of the Linus Pauling Institute (May 16–20, 2003)
  3. Beckman KB, Ames BN (1998) The free radical theory of aging matures. Physiol Rev 78:547–581 [DOI] [PubMed]
  4. Beutler E, Lichtman MA, Coller BS et al. (1995) Williams hematology, 5th edn. McGraw-Hill, New York, pp L26
  5. Brockes C, Buchli C, Locher R et al. (2003) Vitamin E prevents extensive lipid peroxidation in patients with hypertension. Br J Biomed Sci 60:5–8 [DOI] [PubMed]
  6. Brown KM, Morrice PC, Duthie GG (1997) Erythrocyte vitamin E and plasma ascorbate concentrations in relation to erythrocyte peroxidation in smokers and nonsmokers: dose response to vitamin E supplementation. Am J Clin Nutr 65:496–502 [DOI] [PubMed]
  7. Burton GW, Darosewska M (1996) Deuterated vitamin E: measurement in tissues and body fluids. In: Punchard NA, Kelly FJ (eds) Free radicals: a practical approach. Oxford University Press, Oxford, pp 257–270
  8. Burton GW, Ingold TU, Cheeseman KH, Slater TF (1990) Application of deuterated alpha-tocopherols to the biokinetics and bioavailablity of vitamin E. Free Radic Res Commun 11:99–107 [DOI] [PubMed]
  9. Bruunsgaard H, Poulsen HE, Pedersen BK et al (2003) Long-term combined supplementations with alpha-tocopherol and vitamin C have no detectable anti-inflammatory effects in healthy men. J Nutr 133:1170–1173 [DOI] [PubMed]
  10. Carcamo JM, Pedraza A, Borquez-Ojeda O et al (2004) Vitamin C is a kinase inhibitor: dehydroascorbic acid inhibits IkappaBalpha kinase beta. Mol Cell Biol 24:6645–6652 [DOI] [PMC free article] [PubMed]
  11. Carty JL, Bevan R, Waller H et al (2000) The effects of vitamin C supplementation on protein oxidation in healthy volunteers. Biochem Biophys Res Commun 273:729–735 [DOI] [PubMed]
  12. Cone A, Danner T, Ordman AB (1996) Urinary excretion of calcium in students and mature women taking supplements. AGE 19:164
  13. Curhan GC, Willett WC, Rilmm EB, Stampfer MJ (1996) A prospective study of the intake of vitamins C and B6, and the risk of kidney stones in men. J Urol 155:1847–1851 [DOI] [PubMed]
  14. de Zwart, LL, Meerman JH, Commandeur JN, Vermeulen NP (1999) Biomarkers of free radical damage: applications in experimental animals and in humans. Free Radic Biol Med 26:202–226 [DOI] [PubMed]
  15. Fang JC, Kinlay S, Beltrame J et al (2002) Effect of vitamins C and E on progression of transplant-associated arteriosclerosis: a randomised trial. Lancet 359:1108–1113 [DOI] [PubMed]
  16. Haan MN (2003) Can vitamin supplements prevent cognitive decline and dementia in old age. Am J Clin Nutr 77:762–763 [DOI] [PubMed]
  17. Hathcock JN, Azzi A, Blumberg J et al (2005) Vitamins E and C are safe across a broad range of intakes. Am J Clin Nutr 81:736–745 [DOI] [PubMed]
  18. Heitzer TH, Just H, Munzel T (1996) Antioxidant vitamin C improves endothelial dysfunction in chronic smokers. Circulation 94:6–98 [DOI] [PubMed]
  19. Huang H, Appel LJ, Croft KD et al (2002) Effects of vitamin C and vitamin E on in vivo lipid peroxidation: results of a randomized controlled trial. Am J Clin Nutr 76:549–555 [DOI] [PubMed]
  20. Jacob RA, Alello GM, Stephensen CB, Blumberg JB, Milbury PE, Wallock LM, Ames BN (2003) Moderate antioxidant supplementation has no effect on biomarkers of oxidant damage in healthy men with low fruit and vegetable intakes. J Nutr 133:740–743 [DOI] [PubMed]
  21. Jakubowska-Solarska B, Solski J (2000) Sialic acids of young and old red blood cells in healthy subjects. Med Sci Monit 6:871–874 [PubMed]
  22. Johnston CS, Cox SK (2001) Plasma-saturating intakes of vitamin C confer maximal antioxidant protection to plasma. Am J Clin Nutr 20:623–627 [DOI] [PubMed]
  23. King G, Beins M, Larkin J, Summers B, Ordman AB (1994) Rate of excretion of vitamin C in human urine. AGE 17:87–92 [DOI]
  24. Levine M, Conry-Cantilena C, Wang, Y et al (1996) Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance. PNAS USA 93:3704–3709 [DOI] [PMC free article] [PubMed]
  25. Lewis SM, Bain BJ, Bates I, Dacie L (1995) Practical haematology, 8th edn. Churchill Livingstone, London
  26. Losonczy KG, Harris TB, Havlik RJ (1996) Vitamin E and vitamin C supplement use and risk of all-cause and coronary heart disease mortality in older persons: the Established Populations for Epidemiologic Studies of the Elderly. Am J Clin Nutr 64:190–196 [DOI] [PubMed]
  27. Mayne ST (2003) Antioxidant nutrients and chronic disease: use of biomarkers and oxidative stress status in epidemiologic research. J Nutr 133:933S–940S [DOI] [PubMed]
  28. Meydani M (1999) Consensus conference: do vitamins E and C produce beneficial effects on aging and age-related disease? AGE 22:116
  29. Meydani SN, Meydani M, Blumberg JB et al (1997) Vitamin E supplementation and in vivo immune response in healthy elderly subjects. A randomized controlled trial. JAMA 277:1380–1386 [DOI] [PubMed]
  30. NIH (2003, June 26-27) Conference Free Radicals: The Pros and Cons of Antioxidants
  31. Ordman AB (1999) Background for a consensus on the value of consuming vitamin C and E supplements. AGE 22:127
  32. Packer L, Traber MG, Kraiemer K, Frei B (eds) (2002) The antioxidant vitamins C and E. AOCS Press, Champaign [DOI] [PubMed]
  33. Poulsen HE, Weimann A, Salonen JT et al (1998) Does vitamin C have a pro-oxidant effect? Nature 395:231–232 [DOI] [PubMed]
  34. Steinberg FM, Chait A (1998) Antioxidant vitamin supplementation and lipid peroxidation in smokers. Am J Clin Nutr 68:319–327 [DOI] [PubMed]
  35. Traber MG (1999) Vitamin E. In: Shils ME, Olson JA, Shike M, Ross AC (eds) Modern nutrition in health and disease. Williams & Wilkins, Baltimore, pp 347–362
  36. Winklhofer-Roob BM, Ziouzenkova O, Puhl H et al (1995) Impaired resistance to oxidation of low density lipoprotein in cystic fibrosis: improvement during vitamin E supplementation. Free Radic Biol Med 19:725–733 [DOI] [PubMed]
  37. Winterbourn CC, Buss IH (2002) Protein carbonyl measurement by enzyme-linked immunosorbent assay. Methods Enzymol 300:106–111 [DOI] [PubMed]
  38. Yagi K (1998) Simple assay for the level of total lipid peroxides in serum or plasma. In: Armstrong D (ed) Free radical and antioxidant protocols. Barnes & Noble, New York [DOI] [PubMed]

Articles from Age are provided here courtesy of American Aging Association

RESOURCES